Read more
Read less
A webinar presented by the IBA Healthcare and Life Sciences Law Committee and the IBA Intellectual Property and Entertainment Law Committee, Monday 12 January 2026, 1600-1700 UK time.
When technology and intellectual property rights are core assets, licensing to and from commercial partners is an essential part of a company's strategy. Licensing generates revenue, in addition to enhancing a company's value. For start-ups, leveraging on in-house R&D capabilities of large corporations, licensing in and out to strategic partners may secure their business development and increase the probability for new product launches. Figuring out the right steps to take is challenging and requires a dedicated strategy. Join in-house and counselling legal experts in both intellectual property and commercial matters, with long-term experience in the field of life sciences, as they discuss issues relating to licensing and share with participants their knowledge and insight.
Fees
|
IBA member |
Free |
|
Non member |
Free |
Certificate of Attendance
Certificates of attendance for this webinar will be provided to all delegates who have registered in advance and attended the live broadcast for a minimum of 30 minutes based on verified sign-in and sign-out times. The certificate will be sent to the email address provided at the time of registration. Certificates can only be issued to the name provided at the time of registration. If you have any queries relating to your Certificate of Attendance, please email webinars@int-bar.org
Moderator
Confirmed speakers
Maren Müller
Speaker
Grünenthal Pharma, Aachen, Germany
Gesilaine Chaves Bernardi
Speaker
Astellas Pharma , Mexico City, Mexico
Lorenza Ferrari-Hofer
Speaker
Schellenberg Wittmer, Zürich, Switzerland; Intellectual Property and Media Law Committee Liaison Officer, Healthcare and Life Sciences Law Committee